Fig. 10From: Identification and validation of an individualized metabolic prognostic signature for predicting the biochemical recurrence of prostate cancer based on the immune microenvironmentMutation differences between high- and low-risk patients in the TCGA cohort. A The waterfall plot shows mutation information for genes that were mutated in at least 3% of the samples in the high-risk group. B The waterfall plot shows mutation information for genes that were mutated in at least 3% of the samples in the low-risk group. Kaplan–Meier survival curves for the four patient groups stratified by risk score, TP53 mutation status (C), TTN mutation status (D), and SPOP mutation status (E)Back to article page